Nor-NOHA or hydroxy-nor-1-arginine is an arginase-1 inhibitor currently under clinical investigation for the treatment of patients with coronary artery disease suffering from ischemia-reperfusion injury. Here, ARG1 is linked to coronary artery disorder.